Autonomous Mechanical
Infusion Technology
Designed for austere, transport and emergency environments where electronics are a vulnerability.
AXELYUM MEDTECH develops and licenses mechanical medical device technology. PERFU+3 is prepared for industrial transfer and territorial licensing to qualified industrial partners.
PERFU+3 — CIR-V40 pre-industrial prototype
A MedTech intellectual property company
AXELYUM MEDTECH is not a manufacturer. It is a technology developer and licensor, focused on creating transferable mechanical medical device assets.
Based in Sophia Antipolis, Europe's leading technology park, AXELYUM MEDTECH develops protected medical technologies structured for international industrial transfer.
Intellectual property development
AXELYUM creates and protects proprietary mechanical architectures for medical applications. IP assets are structured for licensing, transfer and territorial exploitation.
Technology documentation
From design definition through verification, AXELYUM builds credible, auditable technical dossiers that support industrial transfer and regulatory due diligence.
Industrial transfer preparation
Technology platforms are structured for direct handoff to qualified industrial partners — with frozen baselines, configuration control and structured transfer packages.
Licensing and co-development
AXELYUM engages with industrial partners through territorial licensing, OEM agreements and co-development structures suited to each partner's capabilities and markets.
Company profile
535 Route des Lucioles
06560 Valbonne, France
Fully autonomous mechanical architecture
PERFU+3 operates without any external power source. The entire pressure regulation and safety logic is mechanical and passive.
Passive pressure regulation
A spring-driven pantograph mechanism delivers controlled compression of standard flexible IV bags. Pressure is maintained mechanically throughout the infusion cycle — no power source required at any stage.
Independent safety limiter
A dedicated mechanical limiter caps maximum pressure at ≤ 170 mbar independently of the main actuation mechanism. Safety logic does not depend on software or electronic sensing.
Anti-error Poka-Yoke
A mechanical tubing guide prevents misrouting and anti-pinching. Validated as TV8-A. Incorrect setup is made physically impossible by design.
Industrial transfer architecture
The CIR-V40 baseline is frozen and documented across 10 controlled volumes: design definition, technical annexes, engineering drawings, specifications, validation records and IP portfolio.
A structured patent portfolio
The PERFU+3 IP portfolio covers the core mechanical architecture and its key functional innovations. All filings are French patents with international extension under evaluation.
Core system architecture
Covers the main mechanical pressure regulation architecture — pantograph mechanism, spring drive and passive pressure delivery principle.
Filed — under examinationActuation and ergonomic interface
Covers the cam-driven actuation mechanism and ergonomic arming interface — key differentiators for user operation and human factors.
Filed — under examinationPassive safety architecture
Covers complementary passive safety mechanisms — reinforcing protection across the full operating envelope and extending portfolio coverage.
FiledPre-industrial technology baseline
PERFU+3 is not a commercial product. It is a protected, documented technology opportunity prepared for qualified industrial evaluation and licensing.
Emergency medicine
Pre-hospital and SMUR environments requiring immediate deployment without power infrastructure.
HEMS and medical transport
Helicopter and ground transport where weight, vibration and power constraints limit conventional pumps.
Tactical and military medicine
Field conditions requiring compact, battery-free equipment with no maintenance or recharging dependency.
Disaster response
Mass casualty and degraded environments where electrical infrastructure cannot be assumed.
Remote and austere care
Maritime, polar and mountain environments where battery logistics and cold chain are operational constraints.
Civil protection
Resilience and continuity-of-care scenarios requiring medical equipment independent of any power grid.
Why partner with AXELYUM MEDTECH?
AXELYUM brings a frozen technology baseline, a structured IP portfolio and a complete transfer package. Partners bring manufacturing capability, regulatory execution and market access.
What AXELYUM provides
- Frozen CIR-V40 technology baseline — ready for industrial review
- Structured IP portfolio — 3 French patents, PCT strategy available
- Complete technical transfer package — 10 controlled volumes
- Existing validation data — TV1–TV6 + TV8-A documented
- No legacy manufacturing constraints — technology only
- Flexible licensing structures — territorial, OEM or co-development
Partnership models available
Territorial licensing
Defined geographic scope with agreed royalty structure. Partner executes industrialisation and market access independently.
OEM licensing
Integration of PERFU+3 technology into an existing product line. White-label or co-branded structures available.
Industrial co-development
Joint development toward series production. AXELYUM contributes technology and documentation; partner contributes industrial capability.
IP acquisition
Full or partial transfer of intellectual property assets. Structure defined by target markets and partner strategy.
Qualified industrial discussions welcome
We are seeking qualified discussions with industrial and strategic partners able to assess, validate, industrialise or license the PERFU+3 technology.
Medical device manufacturers
Established MedTech companies seeking to extend their portfolio with a differentiated infusion technology — battery-free and software-free.
Infusion and emergency care OEMs
Infusion system suppliers and emergency care equipment manufacturers with existing distribution and regulatory capability.
Defence and tactical medical
Military medical system integrators and tactical equipment suppliers serving armed forces and civil protection organisations.
Industrial transfer and licensing discussions
PERFU+3 is a protected MedTech technology platform prepared for qualified industrial evaluation. Detailed documentation is available under NDA.
Contact AXELYUM MEDTECH